113 related articles for article (PubMed ID: 8701725)
1. [Study of pharmacokinetics of liver targeting antimalarial agent neoglycoalbumin-primaquine conjugate (NGA-PQ) and primaquine phosphate in mouse].
Li TL; Pang QJ; He YL; Wang P
Yao Xue Xue Bao; 1995; 30(10):721-5. PubMed ID: 8701725
[TBL] [Abstract][Full Text] [Related]
2. [Determination of primaquine and hepatic targeting neoglycoalbumin-primaquine in whole blood and liver of mouse by normalphase high-performance liquid chromatography].
Li T; Pang Q; Jia Y; Wang P; Ma T; Meng J; Zhao S
Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):109-12. PubMed ID: 7657325
[TBL] [Abstract][Full Text] [Related]
3. Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy.
Dierling AM; Cui Z
Int J Pharm; 2005 Oct; 303(1-2):143-52. PubMed ID: 16140485
[TBL] [Abstract][Full Text] [Related]
4. Effects of an NADPH-generating system on primaquine degradation by hamster liver fractions.
Abu-El-Haj S; Allahyari R; Chavez E; Fraser IM; Strother A
Xenobiotica; 1988 Oct; 18(10):1165-78. PubMed ID: 3242312
[TBL] [Abstract][Full Text] [Related]
5. [A preliminary study on the inhibitory action of target-primaqine on the exoerythrocytic forms of Plasmodium yoelii yoelii].
Song J; Wang X; Huang F; Feng C; Zhang Z; Huo Y; Pang Q
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):117-9. PubMed ID: 7554159
[TBL] [Abstract][Full Text] [Related]
6. Toxicology and pharmacokinetics of piperaquine in mice.
Batty KT; Moore BR; Stirling V; Ilett KF; Page-Sharp M; Shilkin KB; Mueller I; Karunajeewa HA; Davis TM
Toxicology; 2008 Jul; 249(1):55-61. PubMed ID: 18502018
[TBL] [Abstract][Full Text] [Related]
7. In vitro metabolism of the antimalarial agent primaquine by mouse liver enzymes and identification of a methemoglobin-forming metabolite.
Strother A; Allahyari R; Buchholz J; Fraser IM; Tilton BE
Drug Metab Dispos; 1984; 12(1):35-44. PubMed ID: 6141909
[TBL] [Abstract][Full Text] [Related]
8. Differential CYP 2D6 metabolism alters primaquine pharmacokinetics.
Potter BM; Xie LH; Vuong C; Zhang J; Zhang P; Duan D; Luong TL; Bandara Herath HM; Dhammika Nanayakkara NP; Tekwani BL; Walker LA; Nolan CK; Sciotti RJ; Zottig VE; Smith PL; Paris RM; Read LT; Li Q; Pybus BS; Sousa JC; Reichard GA; Marcsisin SR
Antimicrob Agents Chemother; 2015 Apr; 59(4):2380-7. PubMed ID: 25645856
[TBL] [Abstract][Full Text] [Related]
9. Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine.
Singh KK; Vingkar SK
Int J Pharm; 2008 Jan; 347(1-2):136-43. PubMed ID: 17709216
[TBL] [Abstract][Full Text] [Related]
10. A nanochitosan-D-galactose formulation increases the accumulation of primaquine in the liver.
Gomes F; Ribeiro AC; Sanches GS; Borges HS; Takahashi LAU; Daniel-Ribeiro CT; Tedesco AC; Nascimento JWL; Carvalho LJM
Antimicrob Agents Chemother; 2024 May; 68(5):e0091523. PubMed ID: 38517190
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of a primaquine prodrug without red blood cell membrane destabilization property.
Davanço MG; Campos ML; Nogueira MA; Campos SL; Marques RV; dos Santos JL; Chin CM; da Fonseca LM; Peccinini RG
Biopharm Drug Dispos; 2012 Nov; 33(8):437-45. PubMed ID: 22899089
[TBL] [Abstract][Full Text] [Related]
12. Photoreactivity of biologically active compounds, XIV: influence of oxygen on light induced reactions of primaquine.
Kristensen S; Nord K; Orsteen AL; Tønnesen HH
Pharmazie; 1998 Feb; 53(2):98-103. PubMed ID: 9540107
[TBL] [Abstract][Full Text] [Related]
13. A newly validated high-performance liquid chromatography method with diode array ultraviolet detection for analysis of the antimalarial drug primaquine in the blood plasma.
Carmo APBD; Borborema M; Ribeiro S; De-Oliveira ACX; Paumgartten FJR; Moreira DL
Rev Soc Bras Med Trop; 2017; 50(4):499-505. PubMed ID: 28954071
[TBL] [Abstract][Full Text] [Related]
14. In Vitro and In Vivo pharmacokinetic studies of bulaquine (analogue of primaquine), a novel antirelapse antimalarial, in rat, rabbit and monkey--highlighting species similarities and differences.
Mehrotra N; Lal J; Puri SK; Madhusudanan KP; Gupta RC
Biopharm Drug Dispos; 2007 Jul; 28(5):209-27. PubMed ID: 17410524
[TBL] [Abstract][Full Text] [Related]
15. The conversion of primaquine into primaquine-aldehyde, primaquine-alcohol, and carboxyprimaquine, a major plasma metabolite.
Frischer H; Mellovitz RL; Ahmad T; Nora MV
J Lab Clin Med; 1991 Jun; 117(6):468-76. PubMed ID: 2045714
[TBL] [Abstract][Full Text] [Related]
16. Toxicological study of the primaquine phosphate loaded chitosan nanoparticles in mice.
Rajera R; Nagpal K; Singh SK; Mishra DN
Int J Biol Macromol; 2013 Nov; 62():18-24. PubMed ID: 23973494
[TBL] [Abstract][Full Text] [Related]
17. [In vitro liver microsomal metabolism of antimalarial primaquine].
Ni YC; Wang MJ; Xu YQ; Hu-Ling
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1992; 10(4):275-8. PubMed ID: 1303335
[TBL] [Abstract][Full Text] [Related]
18. Single-Dose Primaquine in a Preclinical Model of Glucose-6-Phosphate Dehydrogenase Deficiency: Implications for Use in Malaria Transmission-Blocking Programs.
Wickham KS; Baresel PC; Marcsisin SR; Sousa J; Vuong CT; Reichard GA; Campo B; Tekwani BL; Walker LA; Rochford R
Antimicrob Agents Chemother; 2016 Oct; 60(10):5906-13. PubMed ID: 27458212
[TBL] [Abstract][Full Text] [Related]
19. Characterization, in vitro and in vivo studies on primaquine diphosphate liposomes.
Arica B; Ozer AY; Ercan MT; Hincal AA
J Microencapsul; 1995; 12(5):469-85. PubMed ID: 8544091
[TBL] [Abstract][Full Text] [Related]
20. Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: an in vitro study.
Alanazi FK; Harisa Gel-D; Maqboul A; Abdel-Hamid M; Neau SH; Alsarra IA
Arch Pharm Res; 2011 Apr; 34(4):563-71. PubMed ID: 21544721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
